Bugs Bunny reports on Eli Lilly's acquisition of Verve Therapeutics for a cool $1.3 billion, aiming to zap those pesky cholesterol genes. Could this be the cure to Elmer Fudd's heart problems?
Bugs Bunny reports on Eli Lilly's acquisition of Verve Therapeutics for a cool $1.3 billion, aiming to zap those pesky cholesterol genes. Could this be the cure to Elmer Fudd's heart problems?

Of Course Genes Are Acting Funny Now!

Well folks what's up doc? Seems like Eli Lilly that big cheese in the pharma world decided to throw some serious carrots at Verve Therapeutics. A whole $1.3 billion! They're buyin' 'em out! For what you ask? To fiddle with your insides of course specifically your genes related to cholesterol! You know 'cause apparently those genes are actin' a little goofy tryin' to give ya the ol' ticker trouble!

Big Bucks Big Changes Eh?

So Lilly's plunking down $10.50 a share for Verve. That's a 67.5% jump from where Verve was sittin' before. Ka CHING! And get this: almost a billion clams upfront and another $300 million if Verve hits some clinical home runs. Sounds like somebody's bettin' the farm on these gene editing gizmos don't it? I betcha Elmer Fudd is hopin' it means less trips to the doc! That Wascally Wabbit's always getting me worked up and stressing me out!

Partners in Crime or Uh Medicine?

Turns out Lilly and Verve were already thicker than thieves workin' on these fancy gene editing therapies. They're targetin' those PCSK9 ANGPTL3 and LPA genes. Sounds like alphabet soup to me! Apparently they're the culprits behind screwy cholesterol levels. The plan is to pair these gene zappers with other drugs. A regular pharmaceutical cocktail if I do say so myself!

Lilly's Shares Take a Tumble (Just a Little One)

Now here's a funny thing: while Verve's stock was doin' the happy dance Lilly's shares took a bit of a dip. Down 1% before the bell. Eh you win some you lose some right? As I always say "This looks like a job for a genius!" ... or you know a really smart investor.

Is This the End of Cholesterol Troubles?

So what's the big picture here doc? Lilly's clearly lookin' to diversify their portfolio beyond those weight loss and diabetes drugs they're famous for. This gene editing stuff could be the next big thing and if they're trying to lower everyone's cholesterol maybe I can finally eat carrots in peace and not feel guilty for driving up my own!

Th Th That's All Folks! (For Now)

Who knows maybe someday we'll all be gettin' gene edited like a Saturday mornin' cartoon! But for now that's the scoop. Remember folks stay healthy stay hoppy and try not to let Elmer Fudd stress you out too much! "Ain't I a stinker?"


Comments

  • No comments yet. Become a member to post your comments.